Detalhe da pesquisa
1.
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.
Lancet Oncol
; 21(9): 1213-1223, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888453
2.
Patient and oncologist estimates of survival in advanced cancer patients.
Psychooncology
; 20(2): 213-8, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20878829
3.
Excision repair cross complementation group 1 and thymidylate synthase expression in patients with mesothelioma.
Clin Lung Cancer
; 14(2): 164-71, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23085037
4.
The Impact of Hemolysis on Cell-Free microRNA Biomarkers.
Front Genet
; 4: 94, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23745127
5.
Validation of tissue microarray technology in malignant pleural mesothelioma.
Pathology
; 43(2): 128-32, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21233673
6.
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.
Clin Cancer Res
; 16(23): 5805-13, 2010 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20956618